May 4, 2018 / 11:38 AM / 6 months ago

Celgene's quarterly profit dips 9 percent

May 4 (Reuters) - Celgene Corp’s quarterly profit fell about 9 percent despite the U.S. biotech reporting higher revenue, as its expenses surged.

Celgene said on Friday net income fell to $846 million or $1.10 per share in the three months ended March 31, from $932 million or $1.15 per share a year earlier.

Revenue rose 19.4 percent to $3.54 billion. (Reporting by Akankshita Mukhopadhyay in Bengaluru; Editing by Sai Sachin Ravikumar)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below